The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation

Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and apparently sporadic Parkinson disease. LRRK2 is a multidomain protein kinase with autophosphorylation activity. It has previously been shown that the kinase activity of LRRK2 is required for neuronal toxicity, sugge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2008-06, Vol.283 (24), p.16906-16914
Hauptverfasser: Greggio, Elisa, Zambrano, Ibardo, Kaganovich, Alice, Beilina, Alexandra, Taymans, Jean-Marc, Daniëls, Veronique, Lewis, Patrick, Jain, Shushant, Ding, Jinhui, Syed, Ali, Thomas, Kelly J., Baekelandt, Veerle, Cookson, Mark R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 16914
container_issue 24
container_start_page 16906
container_title The Journal of biological chemistry
container_volume 283
creator Greggio, Elisa
Zambrano, Ibardo
Kaganovich, Alice
Beilina, Alexandra
Taymans, Jean-Marc
Daniëls, Veronique
Lewis, Patrick
Jain, Shushant
Ding, Jinhui
Syed, Ali
Thomas, Kelly J.
Baekelandt, Veerle
Cookson, Mark R.
description Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and apparently sporadic Parkinson disease. LRRK2 is a multidomain protein kinase with autophosphorylation activity. It has previously been shown that the kinase activity of LRRK2 is required for neuronal toxicity, suggesting that understanding the mechanism of kinase activation and regulation may be important for the development of specific kinase inhibitors for Parkinson disease treatment. Here, we show that LRRK2 predominantly exists as a dimer under native conditions, a state that appears to be stabilized by multiple domain-domain interactions. Furthermore, an intact C terminus, but not N terminus, is required for autophosphorylation activity. We identify two residues in the activation loop that contribute to the regulation of LRRK2 autophosphorylation. Finally, we demonstrate that LRRK2 undergoes intramolecular autophosphorylation. Together, these results provide insight into the mechanism and regulation of LRRK2 kinase activity.
doi_str_mv 10.1074/jbc.M708718200
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71678086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820714961</els_id><sourcerecordid>71678086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c566t-2e8b1acc62e88125f74f5554d227226ef89fd93e8e7bb61d2c5484e4c98747af3</originalsourceid><addsrcrecordid>eNqFkc-L1DAUx4Mo7uzq1aPmIKKHjkmaJulFWHb9MeyIMs6At5Cmr9OsbTMm7cpe_cvNMIOrB_FBeA_yeV--jy9CTyiZUyL56-vKzj9KoiRVjJB7aEaJyrO8oF_voxkhjGYlK9QJOo3xmqTiJX2ITqjKS6mUmqGf6xbwZxO-uSH6AV-6CCZCZmL01pkRaryEyboBsuBsi1ewAzPiKzckCjP8crlaXbFXeBGxScs9BLxuE7AZaghbDxEvhjGY3ndgp84EfD6Nftf6mF647czo_PAIPWhMF-HxsZ-hzbu364sP2fLT-8XF-TKzhRBjxkBV1Fgr0qAoKxrJm6IoeM2YZExAo8qmLnNQIKtK0JrZgisO3JZKcmma_Ay9OejupqqH2sLeWad3wfUm3GpvnP77Z3Ct3vobzTjLmWBJ4MVRIPjvE8RR9y5a6DozgJ-illRIRZT4L8iIVIILlcD5AbTBxxig-e2GEr3PV6d89V2-aeHpnzfc4cdAE_D8ALRu2_5wAXTlvG2h10zl6RJNRUn2Dp8dsMZ4bbbBRb35wgjNCSkJK8leSB0ISJHcOAg6WgeDhTqJ2lHX3v3L5C-9Vsql</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20786468</pqid></control><display><type>article</type><title>The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Greggio, Elisa ; Zambrano, Ibardo ; Kaganovich, Alice ; Beilina, Alexandra ; Taymans, Jean-Marc ; Daniëls, Veronique ; Lewis, Patrick ; Jain, Shushant ; Ding, Jinhui ; Syed, Ali ; Thomas, Kelly J. ; Baekelandt, Veerle ; Cookson, Mark R.</creator><creatorcontrib>Greggio, Elisa ; Zambrano, Ibardo ; Kaganovich, Alice ; Beilina, Alexandra ; Taymans, Jean-Marc ; Daniëls, Veronique ; Lewis, Patrick ; Jain, Shushant ; Ding, Jinhui ; Syed, Ali ; Thomas, Kelly J. ; Baekelandt, Veerle ; Cookson, Mark R.</creatorcontrib><description>Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and apparently sporadic Parkinson disease. LRRK2 is a multidomain protein kinase with autophosphorylation activity. It has previously been shown that the kinase activity of LRRK2 is required for neuronal toxicity, suggesting that understanding the mechanism of kinase activation and regulation may be important for the development of specific kinase inhibitors for Parkinson disease treatment. Here, we show that LRRK2 predominantly exists as a dimer under native conditions, a state that appears to be stabilized by multiple domain-domain interactions. Furthermore, an intact C terminus, but not N terminus, is required for autophosphorylation activity. We identify two residues in the activation loop that contribute to the regulation of LRRK2 autophosphorylation. Finally, we demonstrate that LRRK2 undergoes intramolecular autophosphorylation. Together, these results provide insight into the mechanism and regulation of LRRK2 kinase activity.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M708718200</identifier><identifier>PMID: 18397888</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Brain - metabolism ; Chlorocebus aethiops ; COS Cells ; Dimerization ; Enzyme Catalysis and Regulation ; Gene Expression Regulation ; Humans ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 ; Models, Biological ; Parkinson Disease - metabolism ; Phosphorylation ; Protein Binding ; Protein Conformation ; Protein Serine-Threonine Kinases - chemistry ; Protein Serine-Threonine Kinases - physiology ; Protein Structure, Tertiary ; Two-Hybrid System Techniques</subject><ispartof>The Journal of biological chemistry, 2008-06, Vol.283 (24), p.16906-16914</ispartof><rights>2008 © 2008 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>Copyright © 2008, The American Society for Biochemistry and Molecular Biology, Inc. 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c566t-2e8b1acc62e88125f74f5554d227226ef89fd93e8e7bb61d2c5484e4c98747af3</citedby><cites>FETCH-LOGICAL-c566t-2e8b1acc62e88125f74f5554d227226ef89fd93e8e7bb61d2c5484e4c98747af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423262/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423262/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18397888$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Greggio, Elisa</creatorcontrib><creatorcontrib>Zambrano, Ibardo</creatorcontrib><creatorcontrib>Kaganovich, Alice</creatorcontrib><creatorcontrib>Beilina, Alexandra</creatorcontrib><creatorcontrib>Taymans, Jean-Marc</creatorcontrib><creatorcontrib>Daniëls, Veronique</creatorcontrib><creatorcontrib>Lewis, Patrick</creatorcontrib><creatorcontrib>Jain, Shushant</creatorcontrib><creatorcontrib>Ding, Jinhui</creatorcontrib><creatorcontrib>Syed, Ali</creatorcontrib><creatorcontrib>Thomas, Kelly J.</creatorcontrib><creatorcontrib>Baekelandt, Veerle</creatorcontrib><creatorcontrib>Cookson, Mark R.</creatorcontrib><title>The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and apparently sporadic Parkinson disease. LRRK2 is a multidomain protein kinase with autophosphorylation activity. It has previously been shown that the kinase activity of LRRK2 is required for neuronal toxicity, suggesting that understanding the mechanism of kinase activation and regulation may be important for the development of specific kinase inhibitors for Parkinson disease treatment. Here, we show that LRRK2 predominantly exists as a dimer under native conditions, a state that appears to be stabilized by multiple domain-domain interactions. Furthermore, an intact C terminus, but not N terminus, is required for autophosphorylation activity. We identify two residues in the activation loop that contribute to the regulation of LRRK2 autophosphorylation. Finally, we demonstrate that LRRK2 undergoes intramolecular autophosphorylation. Together, these results provide insight into the mechanism and regulation of LRRK2 kinase activity.</description><subject>Animals</subject><subject>Brain - metabolism</subject><subject>Chlorocebus aethiops</subject><subject>COS Cells</subject><subject>Dimerization</subject><subject>Enzyme Catalysis and Regulation</subject><subject>Gene Expression Regulation</subject><subject>Humans</subject><subject>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2</subject><subject>Models, Biological</subject><subject>Parkinson Disease - metabolism</subject><subject>Phosphorylation</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Protein Serine-Threonine Kinases - chemistry</subject><subject>Protein Serine-Threonine Kinases - physiology</subject><subject>Protein Structure, Tertiary</subject><subject>Two-Hybrid System Techniques</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc-L1DAUx4Mo7uzq1aPmIKKHjkmaJulFWHb9MeyIMs6At5Cmr9OsbTMm7cpe_cvNMIOrB_FBeA_yeV--jy9CTyiZUyL56-vKzj9KoiRVjJB7aEaJyrO8oF_voxkhjGYlK9QJOo3xmqTiJX2ITqjKS6mUmqGf6xbwZxO-uSH6AV-6CCZCZmL01pkRaryEyboBsuBsi1ewAzPiKzckCjP8crlaXbFXeBGxScs9BLxuE7AZaghbDxEvhjGY3ndgp84EfD6Nftf6mF647czo_PAIPWhMF-HxsZ-hzbu364sP2fLT-8XF-TKzhRBjxkBV1Fgr0qAoKxrJm6IoeM2YZExAo8qmLnNQIKtK0JrZgisO3JZKcmma_Ay9OejupqqH2sLeWad3wfUm3GpvnP77Z3Ct3vobzTjLmWBJ4MVRIPjvE8RR9y5a6DozgJ-illRIRZT4L8iIVIILlcD5AbTBxxig-e2GEr3PV6d89V2-aeHpnzfc4cdAE_D8ALRu2_5wAXTlvG2h10zl6RJNRUn2Dp8dsMZ4bbbBRb35wgjNCSkJK8leSB0ISJHcOAg6WgeDhTqJ2lHX3v3L5C-9Vsql</recordid><startdate>20080613</startdate><enddate>20080613</enddate><creator>Greggio, Elisa</creator><creator>Zambrano, Ibardo</creator><creator>Kaganovich, Alice</creator><creator>Beilina, Alexandra</creator><creator>Taymans, Jean-Marc</creator><creator>Daniëls, Veronique</creator><creator>Lewis, Patrick</creator><creator>Jain, Shushant</creator><creator>Ding, Jinhui</creator><creator>Syed, Ali</creator><creator>Thomas, Kelly J.</creator><creator>Baekelandt, Veerle</creator><creator>Cookson, Mark R.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080613</creationdate><title>The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation</title><author>Greggio, Elisa ; Zambrano, Ibardo ; Kaganovich, Alice ; Beilina, Alexandra ; Taymans, Jean-Marc ; Daniëls, Veronique ; Lewis, Patrick ; Jain, Shushant ; Ding, Jinhui ; Syed, Ali ; Thomas, Kelly J. ; Baekelandt, Veerle ; Cookson, Mark R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c566t-2e8b1acc62e88125f74f5554d227226ef89fd93e8e7bb61d2c5484e4c98747af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Brain - metabolism</topic><topic>Chlorocebus aethiops</topic><topic>COS Cells</topic><topic>Dimerization</topic><topic>Enzyme Catalysis and Regulation</topic><topic>Gene Expression Regulation</topic><topic>Humans</topic><topic>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2</topic><topic>Models, Biological</topic><topic>Parkinson Disease - metabolism</topic><topic>Phosphorylation</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Protein Serine-Threonine Kinases - chemistry</topic><topic>Protein Serine-Threonine Kinases - physiology</topic><topic>Protein Structure, Tertiary</topic><topic>Two-Hybrid System Techniques</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Greggio, Elisa</creatorcontrib><creatorcontrib>Zambrano, Ibardo</creatorcontrib><creatorcontrib>Kaganovich, Alice</creatorcontrib><creatorcontrib>Beilina, Alexandra</creatorcontrib><creatorcontrib>Taymans, Jean-Marc</creatorcontrib><creatorcontrib>Daniëls, Veronique</creatorcontrib><creatorcontrib>Lewis, Patrick</creatorcontrib><creatorcontrib>Jain, Shushant</creatorcontrib><creatorcontrib>Ding, Jinhui</creatorcontrib><creatorcontrib>Syed, Ali</creatorcontrib><creatorcontrib>Thomas, Kelly J.</creatorcontrib><creatorcontrib>Baekelandt, Veerle</creatorcontrib><creatorcontrib>Cookson, Mark R.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Greggio, Elisa</au><au>Zambrano, Ibardo</au><au>Kaganovich, Alice</au><au>Beilina, Alexandra</au><au>Taymans, Jean-Marc</au><au>Daniëls, Veronique</au><au>Lewis, Patrick</au><au>Jain, Shushant</au><au>Ding, Jinhui</au><au>Syed, Ali</au><au>Thomas, Kelly J.</au><au>Baekelandt, Veerle</au><au>Cookson, Mark R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2008-06-13</date><risdate>2008</risdate><volume>283</volume><issue>24</issue><spage>16906</spage><epage>16914</epage><pages>16906-16914</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and apparently sporadic Parkinson disease. LRRK2 is a multidomain protein kinase with autophosphorylation activity. It has previously been shown that the kinase activity of LRRK2 is required for neuronal toxicity, suggesting that understanding the mechanism of kinase activation and regulation may be important for the development of specific kinase inhibitors for Parkinson disease treatment. Here, we show that LRRK2 predominantly exists as a dimer under native conditions, a state that appears to be stabilized by multiple domain-domain interactions. Furthermore, an intact C terminus, but not N terminus, is required for autophosphorylation activity. We identify two residues in the activation loop that contribute to the regulation of LRRK2 autophosphorylation. Finally, we demonstrate that LRRK2 undergoes intramolecular autophosphorylation. Together, these results provide insight into the mechanism and regulation of LRRK2 kinase activity.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>18397888</pmid><doi>10.1074/jbc.M708718200</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2008-06, Vol.283 (24), p.16906-16914
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_71678086
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Animals
Brain - metabolism
Chlorocebus aethiops
COS Cells
Dimerization
Enzyme Catalysis and Regulation
Gene Expression Regulation
Humans
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Models, Biological
Parkinson Disease - metabolism
Phosphorylation
Protein Binding
Protein Conformation
Protein Serine-Threonine Kinases - chemistry
Protein Serine-Threonine Kinases - physiology
Protein Structure, Tertiary
Two-Hybrid System Techniques
title The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A22%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Parkinson%20Disease-associated%20Leucine-rich%20Repeat%20Kinase%202%20(LRRK2)%20Is%20a%20Dimer%20That%20Undergoes%20Intramolecular%20Autophosphorylation&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Greggio,%20Elisa&rft.date=2008-06-13&rft.volume=283&rft.issue=24&rft.spage=16906&rft.epage=16914&rft.pages=16906-16914&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M708718200&rft_dat=%3Cproquest_pubme%3E71678086%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20786468&rft_id=info:pmid/18397888&rft_els_id=S0021925820714961&rfr_iscdi=true